{"id":123297,"name":"GBS/CIDP FOUNDATION INTERNATIONAL","slug":"gbscidp-foundation-international","state":"PA","country":"United States of America","description":"To provide support to those affected by Guillain-Barre syndrome","totalSpending":360000,"filings":36,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":40000},{"year":2020,"income":50000},{"year":2021,"income":40000},{"year":2022,"income":60000},{"year":2023,"income":60000},{"year":2024,"income":50000},{"year":2025,"income":20000}],"issues":["HCR","BUD"],"firms":["HEALTH AND MEDICINE COUNSEL, LLC"],"lobbyists":["DALE DIRKS","DANE CHRISTIANSEN","PHILIP GOGLAS","KATHERINE CRUZ","JOSHUA FEIN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Patient's Access to Treatments Act \n\nGBS/CIDP research at NIH \n\nFDA, Patient Focused Drug Development Initiative \n\nAccess to Marketplace Insurance Act \n\nCIDP, MMN Home Infusion\n\nHealthcare Reform, Pat","FY17 L-HHS Appropriations, Medical Research & Public Health \n\nFY17 DoD Appropriations (Research Programs)\n\nFY18 DoD/HHS Approps","FY17 L-HHS Appropriations, Medical Research & Public Health \n\nFY17 DoD Appropriations (Research Programs)\n\nFY18 DoD/HHS Approps","Patient's Access to Treatments Act \n\nGBS/CIDP research at NIH \n\nFDA, Patient Focused Drug Development Initiative \n\nAccess to Marketplace Insurance Act \n\nCIDP, MMN Home Infusion\n\nHealthcare Reform, Pat","Patient's Access to Treatments Act \n\nGBS/CIDP research at NIH \n\nFDA, Patient Focused Drug Development Initiative \n\nAccess to Marketplace Insurance Act \n\nCIDP, MMN Home Infusion\n\nHealthcare Reform, Pat"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}